Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

scientific article

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1007/S41061-017-0128-5
P932PMC publication ID5480422
P698PubMed publication ID28290155

P50authorRajagopal RameshQ47105152
P2093author name stringAnish Babu
Anupama Munshi
Ranganayaki Muralidharan
Narsireddy Amreddy
P2860cites workNon-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesQ21562142
Global cancer statisticsQ22241238
Polylysine-modified polyethylenimine inducing tumor apoptosis as an efficient gene carrier.Q50857814
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.Q51466557
Biomimetic strategies for targeted nanoparticle delivery.Q55209384
Gene therapy for lung cancerQ58409685
Toxicity of Pluronic F-68Q69501643
Transferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlatesQ71079474
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypesQ71604126
Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNAQ85846218
Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing methodQ40575336
Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryQ40713744
Polyethylenimine-mediated gene delivery: a mechanistic studyQ40810570
Cellular delivery of shRNA using aptamer-conjugated PLL-alkyl-PEI nanoparticlesQ41267425
PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS.Q41781215
Expression of CD44 in human lung tumors.Q42475640
The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH.Q42541130
Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimineQ43804737
pH-sensitive unimolecular polymeric micelles: synthesis of a novel drug carrierQ44513944
Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosisQ44623128
Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapyQ45855846
The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticlesQ45884412
The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathwayQ45887270
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI.Q45888706
Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studiesQ46763514
Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA DeliveryQ47620102
The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA.Q48971998
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticlesQ48972059
Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung CancerQ50326340
Targeted in vivo photodynamic therapy with epidermal growth factor receptor-specific peptide linked nanoparticles.Q38983637
Postoperative radiotherapy for lung cancer: Is it worth the controversy?Q38992790
Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-deliveryQ39247726
Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growthQ39290507
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticlesQ39496907
Targeted drug and gene delivery systems for lung cancer therapyQ39773632
Expression profiling of integrins in lung cancer cellsQ39813409
Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA deliveryQ39831016
Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivoQ39838698
Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cellsQ39842082
Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylationQ39854733
Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancerQ39906541
Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathwayQ39919589
Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro.Q40049006
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.Q40095319
Studies on polyamidoamine dendrimers as efficient gene delivery vectorQ40108825
Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agentsQ40199051
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.Q40204412
Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginineQ40510338
PLGA-based nanoparticles: an overview of biomedical applications.Q37986980
Polyethylenimine as a promising vector for targeted siRNA deliveryQ37995332
RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosisQ38042484
Biomedical applications of carboxymethyl chitosansQ38050253
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrierQ38086322
Nanoparticle-mediated pulmonary drug delivery: a reviewQ38203377
Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapyQ38209539
Non-small-cell lung cancers: a heterogeneous set of diseasesQ38233321
RNA interference: mechanisms, technical challenges, and therapeutic opportunitiesQ38260606
The folate receptor as a rational therapeutic target for personalized cancer treatmentQ38280014
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cellsQ38302239
Principles in the design of ligand-targeted cancer therapeutics and imaging agents.Q38362491
Targeted therapy for non-small cell lung cancer: current standards and the promise of the futureQ38390200
Aerosol delivery of folate-decorated hyperbranched polyspermine complexes to suppress lung tumorigenesis via Akt signaling pathwayQ38738427
Gene delivery to neuroblastoma cells by poly (l-lysine)-grafted low molecular weight polyethylenimine copolymers.Q38775145
siRNA-Loaded Polyion Complex Micelle Decorated with Charge-Conversional Polymer Tuned to Undergo Stepwise Response to Intra-Tumoral and Intra-Endosomal pHs for Exerting Enhanced RNAi EfficacyQ38815969
Nanoparticle-based targeted gene therapy for lung cancerQ38854207
Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.Q38856885
Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insightQ38873132
EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.Q38882303
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscapeQ38922208
CD44 in cancer progression: adhesion, migration and growth regulationQ35875561
Expression of EGFR Is Closely Related to Reduced 3-Year Survival Rate in Chinese Female NSCLCQ36010179
Folate receptor alpha expression in lung cancer: diagnostic and prognostic significanceQ36050687
PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cellsQ36161060
Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapyQ36244267
Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of deliveryQ36303165
Dendrimers in biomedical applications--reflections on the fieldQ36321345
Dendrimers for pharmaceutical and biomedical applicationsQ36367723
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Q36406637
Targeted polymeric nanoparticles for cancer gene therapyQ36416427
Soluble and cell-associated transferrin receptor in lung cancerQ36421973
Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studiesQ36437187
Natural polymers for gene delivery and tissue engineeringQ36500669
Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene deliveryQ36525361
Biological and clinical implications of EGFR mutations in lung cancer.Q36540571
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumorsQ36795709
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexedQ36821156
Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA deliveryQ36858384
Targeted polymeric therapeutic nanoparticles: design, development and clinical translationQ36934007
Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles.Q36951261
Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer modelsQ37013417
Biodegradable polymers as non-viral carriers for plasmid DNA deliveryQ37059381
Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer.Q37065575
Folate-conjugated polyspermine for lung cancer-targeted gene therapyQ37110638
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.Q37126978
Polymeric nanoparticles for siRNA delivery and gene silencingQ37139407
Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.Q37383038
Chitosan-based formulations for delivery of DNA and siRNA.Q37606697
Integrin signaling and lung cancer.Q37688804
The Tumor Microenvironment in Non–Small-Cell Lung CancerQ37777872
Chitosan as a carrier for targeted delivery of small interfering RNAQ37781876
Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryQ37835914
Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery.Q37881431
The ligand nanoparticle conjugation approach for targeted cancer therapyQ37926603
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerQ27021261
Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognitionQ27679502
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyQ27824812
Targeting HIF-1 for cancer therapyQ27860504
Polymeric nanoparticles for targeted treatment in oncology: current insightsQ28087243
The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cellsQ28258883
Molecular mechanisms of RNA interferenceQ28290306
The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?Q28295141
Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer CellsQ28548503
RNA therapeutics: RNAi and antisense mechanisms and clinical applicationsQ28829240
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationQ28829561
Integrins in cancer: biological implications and therapeutic opportunitiesQ29614536
Microenvironmental regulation of tumor progression and metastasisQ29615504
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimineQ29616154
The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cellsQ33360157
Prognostic value of CD44 expression in non-small cell lung cancer: a systematic reviewQ34028901
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cellsQ34075391
Gene therapy in lung cancerQ34107787
Poly(ethylene oxide) grafted with short polyethylenimine gives DNA polyplexes with superior colloidal stability, low cytotoxicity, and potent in vitro gene transfection under serum conditions.Q34160329
Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1.Q34278743
Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer modelQ34293616
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesisQ34367669
EGFR and cancer prognosisQ34399312
Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritisQ34496985
Block copolymer micelles for delivery of gene and related compoundsQ34565334
Integrin alpha v beta 3-targeted imaging of lung cancerQ34768362
Gene therapy progress and prospects cancer: oncolytic viruses.Q34770611
Chitosan and its derivatives--a promising non-viral vector for gene transfectionQ34831284
Review of the oral toxicity of polyvinyl alcohol (PVA).Q35035163
Gene therapy for cancer treatment: past, present and futureQ35040146
Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.Q35100982
Implantable applications of chitin and chitosanQ35109251
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cellsQ35537936
Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivoQ35562133
Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumorsQ35624123
Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locationsQ35831012
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectgene therapyQ213901
manufactured productQ3406743
lung neoplasmQ15124212
biomedical investigative techniqueQ66648976
macromolecular substanceQ75174158
nanoparticleQ61231
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)35
P577publication date2017-03-13
2017-04-01
P1433published inTopics in Current ChemistryQ2443282
P1476titlePolymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment
P478volume375

Reverse relations

cites work (P2860)
Q52726848Hyaluronic Acid Decorated Naringenin Nanoparticles: Appraisal of Chemopreventive and Curative Potential for Lung Cancer.
Q90571402Lipid Polymer Hybrid Nanomaterials for mRNA Delivery
Q50186364Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery.

Search more.